Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+2.65%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$191B
AUM Growth
+$191B
Cap. Flow
-$1.88B
Cap. Flow %
-0.99%
Top 10 Hldgs %
39.72%
Holding
509
New
37
Increased
114
Reduced
203
Closed
17

Top Sells

1
BABA icon
Alibaba
BABA
$2.33B
2
TSLA icon
Tesla
TSLA
$1.55B
3
MRNA icon
Moderna
MRNA
$1.41B
4
AMZN icon
Amazon
AMZN
$884M
5
NTES icon
NetEase
NTES
$692M

Sector Composition

1 Consumer Discretionary 27.71%
2 Healthcare 26.02%
3 Technology 19.32%
4 Communication Services 12.04%
5 Financials 4.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MDRX
451
DELISTED
Veradigm Inc. Common Stock
MDRX
$10K ﹤0.01%
744
ACAD icon
452
Acadia Pharmaceuticals
ACAD
$4.32B
$9K ﹤0.01%
544
AGIO icon
453
Agios Pharmaceuticals
AGIO
$2.33B
$9K ﹤0.01%
186
COLM icon
454
Columbia Sportswear
COLM
$3.09B
$9K ﹤0.01%
95
GAN
455
DELISTED
GAN Ltd
GAN
$9K ﹤0.01%
572
MATV icon
456
Mativ Holdings
MATV
$659M
$9K ﹤0.01%
265
NNDM
457
Nano Dimension
NNDM
$296M
$9K ﹤0.01%
1,600
PTCT icon
458
PTC Therapeutics
PTCT
$4.36B
$9K ﹤0.01%
246
TU icon
459
Telus
TU
$25B
$9K ﹤0.01%
397
DMTK
460
DELISTED
DermTech, Inc. Common Stock
DMTK
$9K ﹤0.01%
286
ONEM
461
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
$9K ﹤0.01%
445
CGNT icon
462
Cognyte Software
CGNT
$630M
$8K ﹤0.01%
369
+66
+22% +$1.43K
FSLY icon
463
Fastly
FSLY
$1.08B
$8K ﹤0.01%
205
MASS icon
464
908 Devices
MASS
$204M
$8K ﹤0.01%
249
SEER icon
465
Seer Inc
SEER
$114M
$8K ﹤0.01%
223
WLY icon
466
John Wiley & Sons Class A
WLY
$2.11B
$8K ﹤0.01%
153
CERS icon
467
Cerus
CERS
$249M
$7K ﹤0.01%
1,143
HI icon
468
Hillenbrand
HI
$1.72B
$7K ﹤0.01%
170
OXM icon
469
Oxford Industries
OXM
$637M
$7K ﹤0.01%
73
VRAY
470
DELISTED
ViewRay, Inc.
VRAY
$7K ﹤0.01%
911
POLY
471
DELISTED
Plantronics, Inc.
POLY
$7K ﹤0.01%
254
CLDR
472
DELISTED
Cloudera, Inc.
CLDR
$7K ﹤0.01%
428
-7,865,045
-100% -$129M
ALKS icon
473
Alkermes
ALKS
$4.96B
$6K ﹤0.01%
192
BMRN icon
474
BioMarin Pharmaceuticals
BMRN
$11.3B
$6K ﹤0.01%
82
INGN icon
475
Inogen
INGN
$210M
$6K ﹤0.01%
141